Rapport Therapeutics (RAPP) Stock News
$RAPP · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Rapport Therapeutics (RAPP) in the past 30 days. BORSA’s news read on RAPP is bullish at 62/100, −1 over 24 hours, based on 2 company events over the past 30 days. RAPP last closed at $28.99 on Oct 13, down 6.93% over five sessions and down 34.11% over the past month. Rapport Therapeutics’ next earnings report is scheduled for Thursday, Nov 5.
The wire on $RAPP
newest first · updated · direct subject stories onlyGuggenheim initiates Rapport Therapeutics coverage with Buy, $65 target
Guggenheim started coverage of Rapport Therapeutics (RAPP) with a Buy rating and a $65 price target.
bullish 70 · impact 30